ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos333.88 M353.8 M349.7 M352.3 M351.9 M1.41 BInvestigación y desarrollo27.65 M26.4 M28.2 M29.5 M28.8 M112.9 MBeneficio operativo216.14 M246 M265.8 M273.2 M316.8 M1.1 BTotal de ingresos no operativos-18.83 M-14.1 M-12.7 M-15.3 M-12.3 M-54.4 MGastos por intereses, netos de intereses capitalizados17.06 M15.9 M14.9 M14.9 M15 M60.7 MIngresos no operativos, una vez deducidos los gastos por intereses-22.44 M-15.9 M-15.1 M-18.2 M-30 M-79.2 MIngresos/gastos extraordinarios3.6 M1.8 M2.4 M2.9 M2.7 M9.8 MBeneficio antes de impuestos197.41 M231.9 M253.1 M257.8 M304.5 M1.05 BParticipación en los beneficios——————Impuestos50.45 M53.9 M60.6 M63.5 M84.2 M262.2 MParticipación minoritaria433 K600 K600 K1.5 M100 K2.8 MOtros ingresos/gastos después de impuestos-3.46 M-14.5 M1.3 M1 M17.8 M5.6 MBeneficio neto antes de actividades interrumpidas146.52 M177.4 M191.9 M192.9 M220.1 M782.3 MOperaciones suspendidas-783 K00000Beneficio neto145.74 M177.4 M191.9 M192.9 M220.1 M782.3 MAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas145.74 M177.4 M191.9 M192.9 M220.1 M782.3 MBeneficio básico por acción1.491.81.951.962.267.97Beneficio por acción diluido1.481.791.941.962.247.93Número medio de acciones ordinarias98.58 M98.4 M98.4 M98.2 M98.2 M—Acciones diluidas99.07 M98.8 M98.8 M98.6 M98.7 M—EBITDA1.18 B365.4 M387.5 M395.1 M1.33 B2.48 BEBIT1.06 B246 M265.8 M273.2 M1.21 B1.99 BCosto de los ingresos—763.1 M814.4 M840.7 M——Otros costes de producción——————Amortización y depreciación (flujo de caja)122.31 M119.4 M121.7 M122 M123.4 M486.5 M
STERIS plc Ordinary Shares
Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.
Steris is listed on the New York Stock Exchange, and is a constituent of the S&P 500 Index. As of 2024, the President and CEO is Daniel A. Carestio.